Karen has served within the medical device, pharmaceutical and in vitro diagnostic industries for 30+ years. She has extensive experience developing strategies for successful US FDA, EU and global regulatory product registrations, and has developed and implemented de novo quality systems in compliance with FDA and ISO standards for several medical device firms. In addition, she possesses broad experience in clinical research and expertise in international Good Clinical Practices standards. Her experience includes responsibility for all aspects of quality, clinical and corporate compliance. Karen has previously served as Vice President, Cardiox Corporation, a privately held company that developed and marketed drug-device combination products, and held regulatory and quality responsible positions for Pharmacia & Upjohn /Pfizer, Phadia Diagnostics, Neoprobe and Serono Laboratories.

Karen Matis

a history of engineering excellence

Flowonix is a medical device company dedicated to helping those who suffer from chronic disorders. Our team has decades of experience developing unique and reliable medical devices to improve quality of life for patients worldwide. Using unique technology that delivers cutting-edge accuracy, Flowonix has developed an implantable drug delivery system designed to deliver therapeutic drugs into the spine. The ultimate goal is to relieve a variety of chronic disorders and help patients return to normal lives.

Please contact us to learn more about Flowonix and the Prometra® Programmable drug delivery device.